Načítá se...
Next-Generation Sequencing and Immunohistochemistry as Future Gold Standard of ALK Testing in Lung Cancer?
A recent study examined the use of fluorescence in situ hybridization (FISH), immunohistochemistry (IHC), and next-generation sequencing (NGS) for the detection of EML4-ALK rearrangement in lung cancer. This letter suggests that although NGS offers an opportunity to obtain additional data concerning...
Uloženo v:
| Vydáno v: | Oncologist |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AlphaMed Press
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4524757/ https://ncbi.nlm.nih.gov/pubmed/26156326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0123 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|